Fusion Pharmaceuticals Inc. Undistributed Earnings of Foreign Subsidiaries
Fusion Pharmaceuticals Inc. had Undistributed Earnings of Foreign Subsidiaries of $6.30 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2024-03-20
- 2023-12-31: Undistributed Earnings of Foreign Subsidiaries $6.30M.
| Period end | Undistributed Earnings of Foreign Subsidiaries |
|---|---|
| 2023-12-31 | $6.30M 10-K · filed 2024-03-20 |